It has become one of the fastest-growing causes of liver failure and liver transplantation. Many people are living with the ...
Silent liver disease may affect 1 in 60 adults over 40, and researchers say early screening could catch damage before ...
Researchers at the University of California San Diego School of Medicine have reported results from a large international ...
New research from the University of Pittsburgh School of Pharmacy sheds light on the processes that lead to liver fibrosis and suggests a novel treatment approach for this common and serious condition ...
The Global Non-Alcoholic Steatohepatitis Treatment Market is entering its first sustained commercial expansion phase as approved therapies create defined prescription pathways for patients with ...
The CDSCO has approved a new indication for Wegovy (semaglutide injection 2.4 mg) for treatment of noncirrhotic metabolic dysfunction associated steatohepatitis (MASH) in adults ...
A research team led by Professor Jinsung Park of the Department of Biomechatronic Engineering at Sungkyunkwan University(SKKU ...
India's drug regulator approved Novo Nordisk's Wegovy for MASH treatment. This drug targets a serious progressive form of ...
Liver fibrosis, a pathological condition in which the liver becomes stiff and scarred, commonly develops in the progression of chronic liver diseases such as chronic hepatitis and metabolic ...
A study of young women referred for PMOS finds high rates of liver steatosis, while commonly used screening tools miss most cases of liver fibrosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results